Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(5 sites)

France

CHU Jean Minjoz, Besançon

Clinique Victor Hugo / Centre Jean Bernard, Le Mans

CHRU Nancy, Nancy

Hôpital Privé du Confluent, Nantes

CH Perpignan, Perpignan